McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic about the company’s performance in 2025. MCK’s growth this year will be ...
Zacks Investment Research on MSN
Why McKesson (MCK) is a top growth stock for the long term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
In its fourth-quarter 2025 earnings announcement, the company revealed plans to spin off its Medical-Surgical Solutions segment into a separate entity, referred to as “NewCo.” Management emphasized ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are trying to figure ...
StockStory.org on MSN
McKesson (NYSE:MCK) reports Q4 CY2025 in line with expectations
Healthcare distributor and services company McKesson (NYSE:MCK) in Q4 CY2025, with sales up 11.4% year on year to $106.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results